-
2
-
-
1642493871
-
The role of long-acting bronchodilators in the management of stable COPD
-
COI: 1:CAS:528:DC%2BD2cXht1ekurw%3D, PID: 14718448
-
Tashkin DP, Cooper CB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125(1):249–59. DOI: 10.1378/chest.125.1.249
-
(2004)
Chest
, vol.125
, Issue.1
, pp. 249-259
-
-
Tashkin, D.P.1
Cooper, C.B.2
-
3
-
-
84903602640
-
Long-acting bronchodilators in COPD: where are we now and where are we going?
-
Cazzola M, Page C. Long-acting bronchodilators in COPD: where are we now and where are we going? Breathe. 2014;10(2):111–20. DOI: 10.1183/20734735.014813
-
(2014)
Breathe
, vol.10
, Issue.2
, pp. 111-120
-
-
Cazzola, M.1
Page, C.2
-
4
-
-
33750115861
-
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease (Review)
-
Appleton S, Poole P, Smith BJ, et al. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease (Review). Cochrane Database Syst Rev. 2006;3:CD001104. doi:10.1002/14651858.CD001104.pub2. DOI: 10.1002/14651858.CD001104.pub2
-
(2006)
Cochrane Database Syst Rev
, Issue.3
-
-
Appleton, S.1
Poole, P.2
Smith, B.J.3
-
5
-
-
2942692139
-
Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD
-
COI: 1:STN:280:DC%2BD2c3ntFWktg%3D%3D, PID: 15170026
-
Man WD, Mustfa N, Nikoletou D, et al. Effect of salmeterol on respiratory muscle activity during exercise in poorly reversible COPD. Thorax. 2004;59(6):471–6. DOI: 10.1136/thx.2003.019620
-
(2004)
Thorax
, vol.59
, Issue.6
, pp. 471-476
-
-
Man, W.D.1
Mustfa, N.2
Nikoletou, D.3
-
6
-
-
3543055330
-
Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
-
PID: 15293609
-
O’Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):86–94. DOI: 10.1183/09031936.04.00072703
-
(2004)
Eur Respir J
, vol.24
, Issue.1
, pp. 86-94
-
-
O’Donnell, D.E.1
Voduc, N.2
Fitzpatrick, M.3
Webb, K.A.4
-
7
-
-
0242577949
-
Contemporary management of chronic obstructive pulmonary disease: scientific review
-
COI: 1:CAS:528:DC%2BD3sXovVCjurc%3D, PID: 14600189
-
Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA. 2003;290(17):2301–12. DOI: 10.1001/jama.290.17.2301
-
(2003)
JAMA
, vol.290
, Issue.17
, pp. 2301-2312
-
-
Sin, D.D.1
McAlister, F.A.2
Man, S.F.3
Anthonisen, N.R.4
-
8
-
-
84963636152
-
A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
-
Feldman G, Maltais F, Khindri S, et al. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD. Int J Chron Obstr Pulm Dis. 2016;11:719–30. DOI: 10.2147/COPD.S102494
-
(2016)
Int J Chron Obstr Pulm Dis
, vol.11
, pp. 719-730
-
-
Feldman, G.1
Maltais, F.2
Khindri, S.3
-
9
-
-
84868554172
-
Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study
-
COI: 1:CAS:528:DC%2BC3sXhsFelt7o%3D, PID: 23060624
-
Kerwin E, Hebert J, Gallagher N, et al. Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study. Eur Respir J. 2012;40(5):1106–14. DOI: 10.1183/09031936.00040712
-
(2012)
Eur Respir J
, vol.40
, Issue.5
, pp. 1106-1114
-
-
Kerwin, E.1
Hebert, J.2
Gallagher, N.3
-
10
-
-
2542603339
-
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
-
PID: 15218994
-
O’Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832–40. DOI: 10.1183/09031936.04.00116004
-
(2004)
Eur Respir J
, vol.23
, Issue.6
, pp. 832-840
-
-
O’Donnell, D.E.1
Fluge, T.2
Gerken, F.3
-
11
-
-
53749102775
-
A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
COI: 1:CAS:528:DC%2BD1cXht1WgsrjJ, PID: 18836213
-
Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–54. DOI: 10.1056/NEJMoa0805800
-
(2008)
N Engl J Med
, vol.359
, Issue.15
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
12
-
-
80053065296
-
Disease severity and symptoms among patients receiving monotherapy for COPD
-
PID: 20886200
-
Dransfield MT, Bailey W, Crater G, Emmett A, O’Dell DM, Yawn B. Disease severity and symptoms among patients receiving monotherapy for COPD. Prim Care Respir J. 2011;20(1):46–53. DOI: 10.4104/pcrj.2010.00059
-
(2011)
Prim Care Respir J
, vol.20
, Issue.1
, pp. 46-53
-
-
Dransfield, M.T.1
Bailey, W.2
Crater, G.3
Emmett, A.4
O’Dell, D.M.5
Yawn, B.6
-
13
-
-
77953232163
-
The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD
-
COI: 1:CAS:528:DC%2BC3cXntlWqurw%3D, PID: 20381630
-
Cazzola M, Molimard M. The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD. Pulm Pharmacol Ther. 2010;23(4):257–67. DOI: 10.1016/j.pupt.2010.03.003
-
(2010)
Pulm Pharmacol Ther
, vol.23
, Issue.4
, pp. 257-267
-
-
Cazzola, M.1
Molimard, M.2
-
14
-
-
61649115167
-
Formoterol and tiotropium compared with tiotropium alone for treatment of COPD
-
PID: 19229704
-
Tashkin DP, Pearle J, Iezzoni D, Varghese ST. Formoterol and tiotropium compared with tiotropium alone for treatment of COPD. COPD. 2009;6(1):17–25. DOI: 10.1080/15412550902724073
-
(2009)
COPD
, vol.6
, Issue.1
, pp. 17-25
-
-
Tashkin, D.P.1
Pearle, J.2
Iezzoni, D.3
Varghese, S.T.4
-
15
-
-
77952914041
-
Combining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptoms
-
PID: 20303247
-
van Noord JA, Aumann JL, Janssens E, et al. Combining tiotropium and salmeterol in COPD: effects on airflow obstruction and symptoms. Respir Med. 2010;104(7):995–1004. DOI: 10.1016/j.rmed.2010.02.017
-
(2010)
Respir Med
, vol.104
, Issue.7
, pp. 995-1004
-
-
van Noord, J.A.1
Aumann, J.L.2
Janssens, E.3
-
16
-
-
84880229392
-
Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study
-
COI: 1:CAS:528:DC%2BC2cXktlahsg%3D%3D, PID: 23722616
-
Bateman ED, Ferguson GT, Barnes N, et al. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J. 2013;42(6):1484–94. DOI: 10.1183/09031936.00200212
-
(2013)
Eur Respir J
, vol.42
, Issue.6
, pp. 1484-1494
-
-
Bateman, E.D.1
Ferguson, G.T.2
Barnes, N.3
-
17
-
-
84901766003
-
Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
-
COI: 1:CAS:528:DC%2BC2cXhtVajtrnN, PID: 24835833
-
Decramer M, Anzueto A, Kerwin E, et al. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. Lancet Respir Med. 2014;2(6):472–86. DOI: 10.1016/S2213-2600(14)70065-7
-
(2014)
Lancet Respir Med
, vol.2
, Issue.6
, pp. 472-486
-
-
Decramer, M.1
Anzueto, A.2
Kerwin, E.3
-
18
-
-
84925396337
-
Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial
-
PID: 25458157
-
Maleki-Yazdi MR, Kaelin T, Richard N, Zvarich M, Church A. Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: results of a 24-week, randomized, controlled trial. Respir Med. 2014;108(12):1752–60. DOI: 10.1016/j.rmed.2014.10.002
-
(2014)
Respir Med
, vol.108
, Issue.12
, pp. 1752-1760
-
-
Maleki-Yazdi, M.R.1
Kaelin, T.2
Richard, N.3
Zvarich, M.4
Church, A.5
-
19
-
-
84877682284
-
Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease
-
COI: 1:CAS:528:DC%2BC3sXot1WnsLg%3D, PID: 23651244
-
Tashkin DP, Ferguson GT. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease. Respir Res. 2013;14:49. DOI: 10.1186/1465-9921-14-49
-
(2013)
Respir Res
, vol.14
, pp. 49
-
-
Tashkin, D.P.1
Ferguson, G.T.2
-
20
-
-
85027923918
-
Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes
-
PID: 22222945
-
van der Molen T, Cazzola M. Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes. Prim Care Respir J. 2012;21(1):101–8. DOI: 10.4104/pcrj.2011.00102
-
(2012)
Prim Care Respir J
, vol.21
, Issue.1
, pp. 101-108
-
-
van der Molen, T.1
Cazzola, M.2
-
21
-
-
84872216479
-
-
Available at, Accessed 24 Oct 2016
-
® Breezhaler® Summary of Product Characteristics. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002679/WC500151255.pdf. Accessed 24 Oct 2016.
-
® Breezhaler® Summary of Product Characteristics
-
-
-
22
-
-
84968769959
-
-
Available at, 24 Oct
-
®. Highlights of prescribing information. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/207930s000lbl.pdf. Accessed 24 Oct 2016.
-
(2016)
Highlights of Prescribing Information
-
-
-
23
-
-
85103353372
-
-
Summary of product characteristics. Available at, Accessed 24 Oct 2016
-
®. Summary of product characteristics. Available at http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002751/WC500168424.pdf. Accessed 24 Oct 2016.
-
-
-
-
24
-
-
85103346386
-
-
Highlights of prescribing information. Available at, Accessed 24 Oct 2016
-
®. Highlights of prescribing information. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203975s000lbl.pdf. Accessed 24 Oct 2016.
-
-
-
-
25
-
-
77952118055
-
-
Available from,. Accessed 24 Oct 2016
-
®. Summary of Product Characteristics. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003745/WC500178413.pdf. Accessed 24 Oct 2016.
-
Summary of Product Characteristics
-
-
-
26
-
-
77952118055
-
-
Available at, Accessed 24 Oct 2016
-
®. Summary of Product Characteristics. Available at https://www.spiolto.com/public/assets/spiolto_spc_published.pdf. Accessed 24 Oct 2016.
-
Summary of Product Characteristics
-
-
-
27
-
-
79960720836
-
-
Available at, Accessed 24 Oct 2016
-
®. Highlights of prescribing information. Available at http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Stiolto%20Respimat/stiolto.pdf. Accessed 24 Oct 2016.
-
Highlights of Prescribing Information
-
-
-
28
-
-
84941207059
-
Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis
-
Huisman EL, Cockle SM, Ismaila AS, Karabis A, Punekar YS. Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis. Int J Chron Obstr Pulm Dis. 2015;10:1863–81.
-
(2015)
Int J Chron Obstr Pulm Dis
, vol.10
, pp. 1863-1881
-
-
Huisman, E.L.1
Cockle, S.M.2
Ismaila, A.S.3
Karabis, A.4
Punekar, Y.S.5
-
30
-
-
85010561746
-
-
Accessed 3 Oct 2016
-
Institute for Quality and Efficiency in Healthcare (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen). Dossier zur Nutzenbewertung gemäß § 35a SGB V. 2013. Available at https://www.g-ba.de/downloads/17-98-3528/2013-04-18_Anl2_6_Modul4.pdf. Accessed 3 Oct 2016.
-
(2013)
Dossier Zur Nutzenbewertung gemäß § 35A SGB
-
-
-
31
-
-
26944454062
-
Simultaneous comparison of multiple treatments: combining direct and indirect evidence
-
PID: 16223826
-
Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005;331(7521):897–900. DOI: 10.1136/bmj.331.7521.897
-
(2005)
BMJ
, vol.331
, Issue.7521
, pp. 897-900
-
-
Caldwell, D.M.1
Ades, A.E.2
Higgins, J.P.3
-
32
-
-
52649100566
-
Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons
-
PID: 18489499
-
Jansen JP, Crawford B, Bergman G, Stam W. Bayesian meta-analysis of multiple treatment comparisons: an introduction to mixed treatment comparisons. Value Health. 2008;11(5):956–64. DOI: 10.1111/j.1524-4733.2008.00347.x
-
(2008)
Value Health
, vol.11
, Issue.5
, pp. 956-964
-
-
Jansen, J.P.1
Crawford, B.2
Bergman, G.3
Stam, W.4
-
33
-
-
5044221416
-
Combination of direct and indirect evidence in mixed treatment comparisons
-
COI: 1:STN:280:DC%2BD2crhvFCqug%3D%3D, PID: 15449338
-
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23(20):3105–24. DOI: 10.1002/sim.1875
-
(2004)
Stat Med
, vol.23
, Issue.20
, pp. 3105-3124
-
-
Lu, G.1
Ades, A.E.2
-
35
-
-
84877131237
-
Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
-
COI: 1:CAS:528:DC%2BC2cXhsFCltL8%3D, PID: 24429126
-
Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med. 2013;1(3):199–209. DOI: 10.1016/S2213-2600(13)70052-3
-
(2013)
Lancet Respir Med
, vol.1
, Issue.3
, pp. 199-209
-
-
Wedzicha, J.A.1
Decramer, M.2
Ficker, J.H.3
-
36
-
-
84885734407
-
Tiotropium respimat inhaler and the risk of death in COPD
-
COI: 1:CAS:528:DC%2BC3sXhs1CgsbzE, PID: 23992515
-
Wise RA, Anzueto A, Cotton D, et al. Tiotropium respimat inhaler and the risk of death in COPD. N Engl J Med. 2013;369(16):1491–501. DOI: 10.1056/NEJMoa1303342
-
(2013)
N Engl J Med
, vol.369
, Issue.16
, pp. 1491-1501
-
-
Wise, R.A.1
Anzueto, A.2
Cotton, D.3
-
37
-
-
84884996543
-
Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis
-
PID: 24093477
-
Cope S, Donohue JF, Jansen JP, et al. Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis. Respir Res. 2013;14:100. DOI: 10.1186/1465-9921-14-100
-
(2013)
Respir Res
, vol.14
, pp. 100
-
-
Cope, S.1
Donohue, J.F.2
Jansen, J.P.3
-
39
-
-
20144382361
-
Minimal clinically important differences in COPD lung function
-
PID: 17136971
-
Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111–24. DOI: 10.1081/COPD-200053377
-
(2005)
COPD
, vol.2
, Issue.1
, pp. 111-124
-
-
Donohue, J.F.1
-
40
-
-
20144362569
-
St. George’s respiratory questionnaire: MCID
-
PID: 17136966
-
Jones PW. St. George’s respiratory questionnaire: MCID. COPD. 2005;2(1):75–9. DOI: 10.1081/COPD-200050513
-
(2005)
COPD
, vol.2
, Issue.1
, pp. 75-79
-
-
Jones, P.W.1
-
41
-
-
84921459850
-
Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study
-
PID: 25404569
-
Singh D, Jones PW, Bateman ED, et al. Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD (ACLIFORM-COPD): a multicentre, randomised study. BMC Pulm Med. 2014;14:178. DOI: 10.1186/1471-2466-14-178
-
(2014)
BMC Pulm Med.
, vol.14
, pp. 178
-
-
Singh, D.1
Jones, P.W.2
Bateman, E.D.3
-
42
-
-
84965085606
-
Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
-
PID: 25756831
-
D’Urzo AD, Rennard SI, Kerwin EM, et al. Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respir Res. 2014;15:123. DOI: 10.1186/s12931-014-0123-0
-
(2014)
Respir Res
, vol.15
, pp. 123
-
-
D’Urzo, A.D.1
Rennard, S.I.2
Kerwin, E.M.3
-
43
-
-
20144372614
-
The MCID of the transition dyspnea index is a total score of one unit
-
PID: 17136969
-
Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005;2(1):99–103. DOI: 10.1081/COPD-200050666
-
(2005)
COPD
, vol.2
, Issue.1
, pp. 99-103
-
-
Mahler, D.A.1
Witek, T.J.2
-
44
-
-
84962324214
-
Dual bronchodilator therapy with umeclidinium/vilanterol versus tiotropium plus indacaterol in chronic obstructive pulmonary disease: a randomized controlled trial
-
COI: 1:CAS:528:DC%2BC28Xltlags78%3D
-
Kalberg C, O’Dell D, Galkin D, Newlands A, Fahy WA. Dual bronchodilator therapy with umeclidinium/vilanterol versus tiotropium plus indacaterol in chronic obstructive pulmonary disease: a randomized controlled trial. Drugs R&D. 2016;16(2):217–27. DOI: 10.1007/s40268-016-0131-2
-
(2016)
Drugs R&D.
, vol.16
, Issue.2
, pp. 217-227
-
-
Kalberg, C.1
O’Dell, D.2
Galkin, D.3
Newlands, A.4
Fahy, W.A.5
-
46
-
-
84925781229
-
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
-
PID: 25677679
-
Buhl R, Gessner C, Schuermann W, et al. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study. Thorax. 2015;70(4):311–9. DOI: 10.1136/thoraxjnl-2014-206345
-
(2015)
Thorax
, vol.70
, Issue.4
, pp. 311-319
-
-
Buhl, R.1
Gessner, C.2
Schuermann, W.3
-
47
-
-
84958166671
-
Efficacy and safety of long-acting beta-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
-
PID: 26490732
-
Oba Y, Sarva ST, Dias S. Efficacy and safety of long-acting beta-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis. Thorax. 2016;71(1):15–25. DOI: 10.1136/thoraxjnl-2014-206732
-
(2016)
Thorax
, vol.71
, Issue.1
, pp. 15-25
-
-
Oba, Y.1
Sarva, S.T.2
Dias, S.3
-
48
-
-
84966586570
-
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD
-
PID: 26923629
-
Calzetta L, Rogliani P, Matera MG, Cazzola M. A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD. Chest. 2016;149(5):1181–96. DOI: 10.1016/j.chest.2016.02.646
-
(2016)
Chest
, vol.149
, Issue.5
, pp. 1181-1196
-
-
Calzetta, L.1
Rogliani, P.2
Matera, M.G.3
Cazzola, M.4
-
49
-
-
77956695739
-
Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations
-
PID: 20565728
-
Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11:79. DOI: 10.1186/1465-9921-11-79
-
(2010)
Respir Res
, vol.11
, pp. 79
-
-
Glaab, T.1
Vogelmeier, C.2
Buhl, R.3
-
50
-
-
85010735445
-
The importance of inhaler devices in the treatment of COPD
-
Bonini M, Usmani OS. The importance of inhaler devices in the treatment of COPD. COPD Res Pract. 2015;1:9. DOI: 10.1186/s40749-015-0011-0
-
(2015)
COPD Res Pract
, vol.1
, pp. 9
-
-
Bonini, M.1
Usmani, O.S.2
-
51
-
-
84949422610
-
Dry powder inhalers and the right things to remember: a concept review
-
Dal Negro RW. Dry powder inhalers and the right things to remember: a concept review. Multidiscip Respir Med. 2015;10(1):13. DOI: 10.1186/s40248-015-0012-5
-
(2015)
Multidiscip Respir Med
, vol.10
, Issue.1
, pp. 13
-
-
Dal Negro, R.W.1
-
52
-
-
38449089896
-
Use of respimat soft mist inhaler in COPD patients
-
COI: 1:CAS:528:DC%2BD28Xhtlars7jO
-
Anderson P. Use of respimat soft mist inhaler in COPD patients. Int J Chron Obstr Pulm Dis. 2006;1(3):251–9.
-
(2006)
Int J Chron Obstr Pulm Dis
, vol.1
, Issue.3
, pp. 251-259
-
-
Anderson, P.1
-
53
-
-
84957604022
-
Acceptability and preference of three inhalation devices assessed by the handling questionnaire in asthma and COPD patients
-
Dal Negro RW, Povero M. Acceptability and preference of three inhalation devices assessed by the handling questionnaire in asthma and COPD patients. Multidiscip Respir Med. 2016;11:7. DOI: 10.1186/s40248-016-0044-5
-
(2016)
Multidiscip Respir Med
, vol.11
, pp. 7
-
-
Dal Negro, R.W.1
Povero, M.2
-
54
-
-
84916942283
-
® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naive Japanese volunteers aged 40 years or older
-
PID: 25525354
-
® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naive Japanese volunteers aged 40 years or older. Int J Chron Obstruct Pulmon Dis. 2014;9:1365–75. DOI: 10.2147/COPD.S72762
-
(2014)
Int J Chron Obstruct Pulmon Dis
, vol.9
, pp. 1365-1375
-
-
Komase, Y.1
Asako, A.2
Kobayashi, A.3
Sharma, R.4
-
55
-
-
84933535700
-
Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study
-
PID: 25927321
-
Pascual S, Feimer J, De Soyza A, et al. Preference, satisfaction and critical errors with Genuair and Breezhaler inhalers in patients with COPD: a randomised, cross-over, multicentre study. NPJ Prim Care Respir Med. 2015;25:15018. DOI: 10.1038/npjpcrm.2015.18
-
(2015)
NPJ Prim Care Respir Med
, vol.25
, pp. 15018
-
-
Pascual, S.1
Feimer, J.2
De Soyza, A.3
-
56
-
-
85017170003
-
Device errors in asthma and COPD: systematic literature review and meta-analysis
-
PID: 28373682
-
Chrystyn H, van der Palen J, Sharma R, et al. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med. 2017;27(1):22. DOI: 10.1038/s41533-017-0016-z
-
(2017)
NPJ Prim Care Respir Med
, vol.27
, Issue.1
, pp. 22
-
-
Chrystyn, H.1
van der Palen, J.2
Sharma, R.3
-
57
-
-
84947027095
-
New developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferences
-
PID: 26439177
-
Ninane V, Vandevoorde J, Cataldo D, et al. New developments in inhaler devices within pharmaceutical companies: a systematic review of the impact on clinical outcomes and patient preferences. Respir Med. 2015;109(11):1430–8. DOI: 10.1016/j.rmed.2015.09.013
-
(2015)
Respir Med
, vol.109
, Issue.11
, pp. 1430-1438
-
-
Ninane, V.1
Vandevoorde, J.2
Cataldo, D.3
-
58
-
-
84892452314
-
A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study
-
PID: 24438744
-
Chapman KR, Beeh KM, Beier J, et al. A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study. BMC Pulm Med. 2014;14:4. DOI: 10.1186/1471-2466-14-4
-
(2014)
BMC Pulm Med
, vol.14
, pp. 4
-
-
Chapman, K.R.1
Beeh, K.M.2
Beier, J.3
-
59
-
-
84960540618
-
Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting beta2-agonists: a systematic review and network meta-analysis
-
COI: 1:CAS:528:DC%2BC2sXntFOrur4%3D, PID: 26746383
-
Schlueter M, Gonzalez-Rojas N, Baldwin M, Groenke L, Voss F, Reason T. Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting beta2-agonists: a systematic review and network meta-analysis. Ther Adv Respir Dis. 2016;10(2):89–104. DOI: 10.1177/1753465815624612
-
(2016)
Ther Adv Respir Dis
, vol.10
, Issue.2
, pp. 89-104
-
-
Schlueter, M.1
Gonzalez-Rojas, N.2
Baldwin, M.3
Groenke, L.4
Voss, F.5
Reason, T.6
-
60
-
-
84878276436
-
Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
-
PID: 20639294
-
Nuesch E, Trelle S, Reichenbach S, et al. Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study. BMJ. 2010;341:c3515. DOI: 10.1136/bmj.c3515
-
(2010)
BMJ
, vol.341
, pp. c3515
-
-
Nuesch, E.1
Trelle, S.2
Reichenbach, S.3
-
61
-
-
0033667445
-
Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature
-
COI: 1:STN:280:DC%2BD3M%2FltV2iug%3D%3D, PID: 11106885
-
Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol. 2000;53(11):1119–29. DOI: 10.1016/S0895-4356(00)00242-0
-
(2000)
J Clin Epidemiol
, vol.53
, Issue.11
, pp. 1119-1129
-
-
Sterne, J.A.1
Gavaghan, D.2
Egger, M.3
|